| scholarly article | Q13442814 |
| P50 | author | Andrew James McMichael | Q21165187 |
| Samuel J McConkey | Q45723532 | ||
| Toyin Togun | Q57895868 | ||
| Marianne Ab van der Sande | Q58805340 | ||
| Richard A Koup | Q97635775 | ||
| P2093 | author name string | Tao Dong | |
| David J Jeffries | |||
| Jason M Brenchley | |||
| Assan Jaye | |||
| Sarah L Rowland-Jones | |||
| Daniel C Douek | |||
| Hilton C Whittle | |||
| Abraham S Alabi | |||
| Melody G Duvall | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6973-6981 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection | |
| P478 | volume | 176 |
| Q35628697 | A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations |
| Q46498843 | An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa |
| Q37312729 | CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection |
| Q34035802 | Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis |
| Q37307096 | Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France |
| Q44457386 | Comprehensive analysis of HIV Gag-specific IFN-gamma response in HIV-1- and HIV-2-infected asymptomatic patients from a clinical cohort in The Gambia |
| Q36315149 | Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection |
| Q37344826 | Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load |
| Q22241984 | Emerging concepts in the immunopathogenesis of AIDS |
| Q38717198 | Engineering broadly neutralizing antibodies for HIV prevention and therapy |
| Q39005000 | Freeze-thaw lysates of Plasmodium falciparum-infected red blood cells induce differentiation of functionally competent regulatory T cells from memory T cells |
| Q36898820 | Gag-specific CD4+ T-cell frequency is inversely correlated with proviral load and directly correlated with immune activation in infection with human immunodeficiency virus type 2 (HIV-2) but not HIV-1. |
| Q37341025 | HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies |
| Q36770954 | HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs |
| Q93104023 | HIV-2 as a model to identify a functional HIV cure |
| Q33966596 | HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients |
| Q41548052 | HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells |
| Q36845911 | Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection |
| Q56787219 | Highly avid, oligoclonal, early-differentiated antigen-specific CD8+ T cells in chronic HIV-2 infection |
| Q30404393 | Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review |
| Q33679745 | Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants |
| Q64237765 | Immune signatures for HIV-1 and HIV-2 induced CD4T cell dysregulation in an Indian cohort |
| Q33427803 | Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection |
| Q63408431 | Immunological correlates of protection from HIV infection and disease |
| Q59098671 | Immunology and the elusive AIDS vaccine |
| Q35621704 | Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. |
| Q34046201 | Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa |
| Q42318282 | Insight into HIV-2 latency may disclose strategies for a cure for HIV-1 infection |
| Q92075372 | Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection |
| Q38086432 | Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses |
| Q35947577 | Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection |
| Q83358553 | Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis |
| Q35947812 | Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells |
| Q84325970 | Neutralizing antibodies in SIV control: co-impact with T cells |
| Q36765448 | Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? |
| Q33715552 | Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections |
| Q36618086 | Polyfunctional T cell responses are a hallmark of HIV-2 infection |
| Q34430261 | Postnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function |
| Q35665765 | Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes |
| Q36895619 | Protective immunity against HIV infection: lessons from HIV-2 infection |
| Q35970916 | Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection |
| Q35947958 | Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection |
| Q37789345 | T cell immunity in acute HIV-1 infection. |
| Q30014840 | T-cell quality in memory and protection: implications for vaccine design |
| Q34642996 | The T-cell response to HIV. |
Search more.